Franciscan VNS Home Care pays $3.65M to settle overtime claims
Occupational therapists, physical therapists and registered nurses have received payments from the settlement, while almost a third will go toward attorney fees.
Health Care & Insurance
Articles
European regulators says Lilly Alzheimer’s drug shouldn’t get marketing approval
The European Medicines Agency committee said the benefits of the new drug, Kisunla, did not outweigh the risks, and it recommended refusing marketing authorization for it.
Department of Health and Human Services to lay off 10,000 workers in major restructuring
The plan means cuts at the Food and Drug Administration, the Centers for Disease Control and Prevention, the National Institutes of Health, and the Centers for Medicare and Medicaid Services.
Facing high demand and staffing shortages, Eskenazi Health automates some prescription fulfillment
Eskenazi Health officials say the system has seen a 60% increase in the number of prescriptions filled over the past five years—a rate that’s unsustainable, given national staffing shortages.
Trump administration to pull back $11B in COVID funding from local health departments
The Department of Health and Human Services said it would “no longer waste billions of taxpayer dollars responding to a non-existent pandemic that Americans moved on from years ago.”
Proposed legislation could impact Indiana health care mergers
Health care mergers and acquisitions continue to be a hot topic in Indiana, with the Legislature considering a bill this year geared toward creating more transparency and state oversight toward those deals.
Johnson & Johnson plans $55B in United States investments
Aside from building four new plants, Johnson & Johnson said that it will expand several existing sites.
Senate committee advances hospital price bill, but expects more changes
Members of the Indiana Senate Committee on Health and Provider Services agreed with the need to address the high cost of health care. But they often disagreed with the approach of House Bill 1004.
‘Not a deadbeat’: House amends out cap on Medicaid plan, keeps work requirements
In Tuesday’s committee hearing, conservative lawmakers defended the plan to add red tape and bureaucracy to the program against Hoosiers who were worried they’d lose their health coverage.
Marian students publish research on high-risk behavior of U.S. medical students
The study looked at the behaviors of more than 550 medical school students from across the country to understand how these young professionals cope with the stress of their programs.
As AI nurses reshape hospital care, human nurses are pushing back
Hospitals say AI is helping nurses work more efficiently while addressing burnout and understaffing. But nursing unions argue the technology is overriding nurses’ expertise and degrading the quality of care patients receive.
Big Ten schools team up when it comes to cancer research
Indianapolis has been awash in Big Ten logos amid the conference’s basketball tournaments. But Indy is home to another sort of Big Ten gathering—one focused on improving cancer research.
Federal judge blocks drastic funding cuts to medical research
Separate lawsuits filed by a group of 22 states plus organizations representing universities, hospitals and research institutions nationwide sued to stop the cuts, saying they would cause “irreparable harm.”
Novo Nordisk cuts Wegovy prices, following similar move for Zepbound by Eli Lilly
Novo Nordisk’s new offering follows a direct-to-consumer model that Eli Lilly launched last year.
Startup Emboa Medical’s device mimics boa constrictor’s teeth to remove blood clots
The pre-clinical West Lafayette-based medical device startup is working to develop a new “microstructred” catheter to remove blood clots that cause strokes.
Lilly cuts undisclosed number of jobs, ‘nothing large scale’
The reductions come at a time of significant growth overall for Lilly. and soon after the announcement of plans to build new manufacturing facilities at four yet-to-be-named U.S. locations.
IU Health reports higher annual revenue as patient numbers rise
IU Health said inpatient and outpatient surgeries returned to levels last year not seen since before the COVID-19 pandemic.
Study co-authored by IU researcher finds generic drugs made in India have more severe adverse events
The results showed that the number of severe adverse events for patients was 54.3% higher than that of drugs made in emerging economies.
Patients struggle with lack of consistent coverage for popular weight-loss drugs
Supplies of high-demand obesity treatments are improving, but that doesn’t mean they’re easier to get.
Weight-loss drugs aren’t just slimming waists. They’re shifting the economy.
Roughly 16 million people—that’s 6 percent of American adults—are taking GLP-1 weight-loss drugs, and that number is growing rapidly. Their collective purchasing power has the potential to profoundly reshape the economy.